Sign in to view content

Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks

Pauline T. Merrill, MD, FASRS

Video
Published 2019

Pauline T. Merrill, MD

Inflammatory and Infectious Diseases Symposium

Related

An analysis of the phase 2 trial with intraviteal aflibercept and suprachoroidal
Michael A. Singer, MD
Updates from the Field
2017
Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis following an Injectable Fluocinolone Acetonide Insert
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2020
Inflammatory and Infectious Diseases Take-Home Panel
Sunil Srivastava, MD
Annual Meeting Talks
2019

Category: Inflammatory and Infectious Diseases

Steroids

See more